Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Comparative Analysis of Biological and Functional Properties of Bone Marrow Mesenchymal Stromal Cells Expanded in Media with Different Platelet Lysate Content.

Skific M, Golemovic M, Crkvenac-Gornik K, Vrhovac R, Golubic Cepulic B.

Cells Tissues Organs. 2018;205(4):226-239. doi: 10.1159/000492581. Epub 2018 Sep 17.

PMID:
30223277
2.

Treatment of chronic GVHD with extracorporeal photochemotherapy.

Bojanic I, Serventi Seiwerth R, Golubic Cepulic B, Mazic S, Lukic M, Raos M, Plenkovic F, Golemovic M, Dubravcic K, Perkovic S, Batinic D, Labar B.

Transfus Apher Sci. 2013 Apr;48(2):193-4. doi: 10.1016/j.transci.2013.02.033. Epub 2013 Mar 17. No abstract available.

PMID:
23809831
3.

The organic arsenic derivative GMZ27 induces PML-RARα-independent apoptosis in myeloid leukemia cells.

Cheng X, Quintás-Cardama A, Golemovic M, Zingaro R, Gao MZ, Freireich EJ, Andreeff M, Kantarjian HM, Verstovsek S.

Anticancer Res. 2012 Jul;32(7):2871-80.

4.

[Mesenchymal stem cells: immunomodulatory properties and clinical application].

Golemović M, Skifić M, Cepulić BG.

Lijec Vjesn. 2012 Jan-Feb;134(1-2):42-9. Review. Croatian.

PMID:
22519252
5.

MER1, a novel organic arsenic derivative, has potent PML-RARalpha-independent cytotoxic activity against leukemia cells.

Golemovic M, Quintás-Cardama A, Manshouri T, Orsolic N, Duzkale H, Johansen M, Freireich EJ, Kantarjian H, Zingaro RA, Verstovsek S.

Invest New Drugs. 2010 Aug;28(4):402-12. doi: 10.1007/s10637-009-9267-z. Epub 2009 May 26.

6.

Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells.

Orsolic N, Golemovic M, Quintás-Cardama A, Scappini B, Manshouri T, Chandra J, Basic I, Giles F, Kantarjian H, Verstovsek S.

Cancer Sci. 2006 Sep;97(9):952-60. Epub 2006 Jul 4.

7.

IgH and TCRgamma gene rearrangements, cyclin A1 and HOXA9 gene expression in biphenotypic acute leukemias.

Golemović M, Sucić M, Zadro R, Mrsić S, Mikulić M, Labar B, Rajić LJ, Batinić D.

Leuk Res. 2006 Feb;30(2):211-21. Epub 2005 Aug 15.

PMID:
16102826
8.

AMN107, a novel aminopyrimidine inhibitor of p190 Bcr-Abl activation and of in vitro proliferation of Philadelphia-positive acute lymphoblastic leukemia cells.

Verstovsek S, Golemovic M, Kantarjian H, Manshouri T, Estrov Z, Manley P, Sun T, Arlinghaus RB, Alland L, Dugan M, Cortes J, Giles F, Beran M.

Cancer. 2005 Sep 15;104(6):1230-6.

9.

AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, has in vitro activity against imatinib-resistant chronic myeloid leukemia.

Golemovic M, Verstovsek S, Giles F, Cortes J, Manshouri T, Manley PW, Mestan J, Dugan M, Alland L, Griffin JD, Arlinghaus RB, Sun T, Kantarjian H, Beran M.

Clin Cancer Res. 2005 Jul 1;11(13):4941-7.

10.

Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: preclinical evaluation.

Orsolic N, Giles FJ, Gourdeau H, Golemovic M, Beran M, Cortes J, Freireich EJ, Kantarjian H, Verstovsek S.

Br J Haematol. 2004 Mar;124(6):727-38.

PMID:
15009060
11.

In vitro activity of dimethylarsinic acid against human leukemia and multiple myeloma cell lines.

Duzkale H, Jilani I, Orsolic N, Zingaro RA, Golemovic M, Giles FJ, Kantarjian H, Albitar M, Freireich EJ, Verstovsek S.

Cancer Chemother Pharmacol. 2003 May;51(5):427-32. Epub 2003 Mar 26.

PMID:
12736761
12.

[Origin and development of haematopoietic cells].

Golemović M, Batinić D.

Lijec Vjesn. 2002 Jun-Jul;124(6-7):203-11. Review. Croatian.

PMID:
19658338
13.

Double immunoenzymatic APAAP staining for the detection of leukemia-associated immunophenotypes.

Sucić M, Boban D, Marković-Glamocak M, Uzarević B, Zadro R, Petrovecki M, Ries S, Gjadrov K, Golemović M, Stavljenić-Rukavina A, Labar B, Batinić D.

J Hematother Stem Cell Res. 1999 Dec;8(6):635-43.

PMID:
10645771

Supplemental Content

Loading ...
Support Center